Blackmores' practitioner-only firm BioCeuticals is investing heavily in medicinal cannabis research, recently announcing its $500,000-plus funding of the world's first clinical trial to investigate its effects on brain tumours and the symptoms...
A company developing a pharmaceutical chewing gum containing cannabinoids extracted from marijuana has announced plans to build a manufacturing facility in the Netherlands.